ViroXis

ViroXis

Develops botanical pharmaceuticals derived from sandalwood oil. Learn more

Launch date
Market cap
-
Enterprise valuation
AUD15—23m (Dealroom.co estimates Oct 2010.)
San Antonio Texas (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$501k

Debt

$2.5m

Series A

$1.0m

Early VC

$7.8m

Growth Equity VC
*

N/A

Acquisition
Total FundingAUD17.5m

Recent News about ViroXis

Edit
More about ViroXisinfo icon
Edit

Viroxis operates in the global wellness market, focusing on the sustainable supply and commercialization of Sandalwood Album, a unique ingredient with a rich history spanning over 2000 years. The company serves a diverse clientele, including cosmetic manufacturers, wellness brands, and pharmaceutical companies, leveraging the multifaceted benefits of Sandalwood Album. Viroxis's business model revolves around cultivating and harvesting Sandalwood Album sustainably, ensuring a continuous and eco-friendly supply chain. Revenue is generated through the sale of raw sandalwood, processed extracts, and proprietary formulations to various industries. By positioning itself as the world's first and only sustainable supplier of this endangered species, Viroxis taps into the growing demand for natural and ethically sourced wellness ingredients. The company also invests in research and development to explore new applications and benefits of Sandalwood Album, further enhancing its market appeal.

Keywords: Sandalwood Album, sustainable supply, wellness market, cosmetic manufacturers, pharmaceutical companies, eco-friendly, natural ingredients, proprietary formulations, research and development, ethical sourcing.